Gapping down
In reaction to earnings/guidance:
- COLM -16.9% (also announces senior leadership changes; COO to retire), TWTR -15.5%, LOCO -14.8%, PRO -7.7%, NUVA -6.7%, TEAM -5.8%, MGM -5.7%, MTZ -5.1%, SGEN -4.6%, ATSG -4.5%, X -4.4%, SHAK -4.3%, AAPL -4.1%, COG -4.1%, MDRX -4%, LPSN -3.8%, FND -3.7%, FTAI -3.7%, RRC -3.6%, BLDR -3.4%, NVST -3.3%, SKX -3.2%, PFPT -3.1%, VCRA -3.1%, ETH -2.8%, ADM -2.8%, CHTR -2.8%, BAND -2.6%, CAR -1.9%, SBUX -1.8%, PEG -1.7%, KNSL -1.6%, ILMN -1.6%, AMZN -1.5%, ATVI -1.4%, SYK -1.2%, FB -1.1%, DVN -1.1%, QDEL -1%, VRTX -1%, HON -1%, WU -0.9%, HIG -0.9%, KBR -0.9%, NVO -0.9%
Other news:
- AXGT -32.1% (to present AXO-Lenti-PD program during virtual Parkinson's Disease R&D Day)
- OPK -7.9% (shareholder Sian Capital releases presentation outlining paths to value creation; also reports earnings)
- FE -7.1% (terminates CEO Charles Jones and two other executives)
- ARCH -6.2% (prices offering of $135 mln of 5.25% convertible senior notes due 2025)
- GLPI -2.1% (stock offering)
- FSLY -2% (updated its shareholder letter issued on October 28, 2020)
- WRTC -1.8% (CEO steps down)
- HCAT -1.4% (announces partnership with Middle East Healthcare)
- ACB -1% (obtains receipt for final base shelf prospectus, reiterates fiscal Q1 guidance, expects full compliance with all fiscal Q1 financial covenants) .
Analyst comments:
- TEAM -6.5% (downgraded to Hold from Buy at Truist)
- BPMC -2.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- YNDX -2.1% (downgraded to Hold from Buy at Jefferies)